Institution · Kinderkrankenhaus auf der Bult

Most cited papers from Kinderkrankenhaus auf der Bult

Kinderkrankenhaus auf der Bult

What are the most cited papers from Kinderkrankenhaus auf der Bult?

The most cited paper from Kinderkrankenhaus auf der Bult is "Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range" (Tadej Battelino et al., 2019), with 4,012 citations. Next come "International Consensus on Use of Continuous Glucose Monitoring" (2,082) and "Continuous glucose monitoring and metrics for clinical trials: an international consensus statement" (811).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 120 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range Tadej Battelino et al. · Diabetes Care Open access	8 Jun 2019	4,012
2	International Consensus on Use of Continuous Glucose Monitoring Thomas Danne et al. · Diabetes Care Open access	10 Nov 2017	2,082
3	Continuous glucose monitoring and metrics for clinical trials: an international consensus statement Tadej Battelino et al. · The Lancet Diabetes & Endocrinology Open access	6 Dec 2022	811
4	Anaphylaxis in children and adolescents: The European Anaphylaxis Registry Linus Grabenhenrich et al. · Journal of Allergy and Clinical Immunology	21 Jan 2016	612
5	Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57 Deborah Mackay, Jonathan L A Callaway, Sophie M Marks et al. · Nature Genetics	11 Jul 2008	544
6	Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial Wolfgang Göpel, Angela Kribs, Andreas Ziegler et al. · The Lancet	30 Sep 2011	475
7	European Resuscitation Council Guidelines for Resuscitation 2015 Ian K. Maconochie, Robert M. Bingham, Christoph Bernhard Eich et al. · Resuscitation Open access	Oct 2015	453
8	Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes Beate Karges, Anke Schwandt, Bettina Heidtmann et al. · JAMA Open access	10 Oct 2017	451
9	Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice Moshe Phillip et al. · Endocrine Reviews Open access	6 Sep 2022	439
10	Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp Moshe Phillip, Tadej Battelino, Eran Atlas et al. · New England Journal of Medicine Open access	27 Feb 2013	436
11	International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors Thomas Danne et al. · Diabetes Care Open access	6 Feb 2019	373
12	A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial Richard M. Bergenstal et al. · The Lancet Open access	2021	342
13	GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus Johnny Ludvigsson, David M. Krisky, Rosaura Casas et al. · New England Journal of Medicine	Feb 2012	341
14	New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes Henrik Bindesbøl Mortensen, Philip Hougaard, Peter Swift et al. · Diabetes Care Open access	12 May 2009	320
15	Use of Insulin Pump Therapy in the Pediatric Age-Group Moshe Phillip, Tadej Battelino, Henry Rodriguez et al. · Diabetes Care	25 May 2007	319
16	Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany Clemens Kamrath, Kirsten Mönkemöller, Torben Biester et al. · JAMA Open access	20 Jul 2020	316
17	Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group Eva Rebelo Gomes, Knut Brockow, Semanur Kuyucu et al. · Allergy Open access	28 Sep 2015	281
18	Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective Emily K. Sims, Rachel E.J. Besser, Colin Mark Dayan et al. · Diabetes Open access	22 Mar 2022	249
19	Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes Revital Nimri et al. · Nature Medicine	Sep 2020	245
20	Genotypic and Phenotypic Spectrum in Tricho-Rhino-Phalangeal Syndrome Types I and III H.‐J. Lüdecke et al. · The American Journal of Human Genetics Open access	2001	235
21	ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes Thomas Danne, Moshe Phillip, Bruce A. Buckingham et al. · Pediatric Diabetes Open access	12 Jul 2018	229
22	Mutations in the β-tropomyosin (TPM2) gene – a rare cause of nemaline myopathy Kati M. Donner, Miina Ollikainen, Maaret Ridanpää et al. · Neuromuscular Disorders	Feb 2002	227
23	Continuing Stability of Center Differences in Pediatric Diabetes Care: Do Advances in Diabetes Treatment Improve Outcome? Carine E. de Beaufort et al. · Diabetes Care Open access	28 Aug 2007	217
24	Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study Manju A. Kurian et al. · The Lancet Neurology Open access	27 Nov 2010	211
25	A recessive form of central core disease, transiently presenting as multi‐minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene Ana Ferreiro, Nicole Monnier, Norma Beatriz Romero et al. · Annals of Neurology	21 May 2002	203
26	Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017 Louisa van den Boom, Beate Karges, Marie Auzanneau et al. · Diabetes Care	5 Sep 2019	192
27	Pyridoxine-Dependent Epilepsy: An Expanding Clinical Spectrum Clara van Karnebeek, Sylvia A. Tiebout, J.M.F. Niermeijer et al. · Pediatric Neurology	11 Jan 2016	186
28	Guideline for the diagnosis of drug hypersensitivity reactions Knut Brockow et al. · Allergo Journal International Open access	May 2015	184
29	A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes Tim Heise, Thomas Rudolf Pieber, Thomas Danne et al. · Clinical Pharmacokinetics Open access	15 Feb 2017	182
30	Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes? Fergus Cameron et al. · Diabetic Medicine Open access	20 Feb 2008	181
31	Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism C. Seifarth, Stefan Trenkel, Hans-Paul Schobel et al. · Clinical Endocrinology	27 Sep 2002	178
32	Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study Barbara J. Anderson, Lori M. Laffel, Catherine Domenger et al. · Diabetes Care Open access	25 May 2017	173
33	MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover Trial Revital Nimri, Ido Muller, Eran Atlas et al. · Diabetes Care	31 Jul 2014	171
34	Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany? Sascha René Tittel, Joachim Rosenbauer, Clemens Kamrath et al. · Diabetes Care Open access	21 Aug 2020	170
35	Hydrolyzed Infant Formula and Early β-Cell Autoimmunity Mikael Knip, Hans K. Åkerblom, DOROTHY J. BECKER et al. · JAMA Open access	10 Jun 2014	169
36	Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics Paolo Pozzilli, Tadej Battelino, Thomas Danne et al. · Diabetes/Metabolism Research and Reviews Open access	13 Apr 2015	160
37	Genotype–phenotype associations in WT1 glomerulopathy Beata Stefania Lipska-Ziętkiewicz et al. · Kidney International Open access	8 Jan 2014	159
38	Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes Writing Group for the TRIGR Study Group et al. · JAMA Open access	2 Jan 2018	156
39	Diabetic retinopathy in type 1 diabetes—a contemporary analysis of 8,784 patients on behalf of the DPV–Wiss Study Group, Hans‐Peter Hammes, W. Kerner et al. · Diabetologia Open access	3 Jun 2011	154
40	Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy Thomas Danne, Olga Kordonouri, Martin Holder et al. · Diabetes Technology & Therapeutics	9 Aug 2011	152
41	ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery Jennifer L. Sherr, Melissa J. Schoelwer, Tiago Jeronimo Dos Santos et al. · Pediatric Diabetes Open access	Dec 2022	151
42	Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes Thomas Danne, Kerstin Lüpke, Kerstin Walte et al. · Diabetes Care Open access	Nov 2003	151
43	Outcome of extremely low birth weight survivors at school age: the influence of perinatal parameters on neurodevelopment Achim‐Peter Neubauer, W Voss, E Kattner · European Journal of Pediatrics	26 Feb 2007	150
44	The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction Moshe Phillip, Richard M. Bergenstal, Kelly L. Close et al. · Diabetes Technology & Therapeutics Open access	9 Sep 2020	145
45	Glimepiride Versus Metformin as Monotherapy in Pediatric Patients With Type 2 Diabetes Michael Everett Gottschalk, Thomas Danne, Aleksandra Vlajnic et al. · Diabetes Care	29 Mar 2007	143
46	Insulin treatment in children and adolescents with diabetes Hans‐Jacob Bangstad, Thomas Danne, Larry C. Deeb et al. · Pediatric Diabetes	28 Aug 2009	142
47	Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries and the PedPump Study Group et al. · Diabetologia Open access	30 Jun 2008	140
48	ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes Farid H. Mahmud, Nancy Samir Elbarbary, Elke Elisabeth Fröhlich-Reiterer et al. · Pediatric Diabetes Open access	Aug 2018	138
49	Diabetes education in children and adolescents Karin Lange, Peter Swift, Ewa Pańkowska et al. · Pediatric Diabetes	Sep 2014	136
50	Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005 PGF Swift et al. · Pediatric Diabetes Open access	6 Nov 2009	133

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.